Cerebral shunt

From WikiMD's WELLNESSPEDIA

Introduction[edit]

Cerebral Shunts are medical devices used to treat hydrocephalus, a condition characterized by the excessive accumulation of cerebrospinal fluid (CSF) in the brain. This accumulation can lead to increased intracranial pressure (ICP), posing serious risks such as brain tissue damage and herniation. Cerebral shunts help to divert the excess fluid and relieve these pressures.

Overview of Hydrocephalus and Cerebral Shunts[edit]

  • Hydrocephalus: A neurological condition where an abnormal accumulation of CSF causes pressure on the brain.
  • Purpose of Cerebral Shunts: To redirect excess CSF from the brain to another part of the body where it can be absorbed.
File:Diagram showing a brain shunt CRUK 052.svg
Cerebral Shunt Device

Types of Cerebral Shunts[edit]

  • Ventriculoperitoneal (VP) Shunt: Diverts fluid from the ventricles of the brain to the peritoneal cavity.
  • Ventriculoatrial (VA) Shunt: Redirects CSF from the ventricles to the right atrium of the heart.
  • Lumboperitoneal (LP) Shunt: Drains CSF from the lumbar spinal cord to the peritoneal cavity.

Indications for Cerebral Shunt Placement[edit]

  • Cerebral shunts are primarily used in the treatment of hydrocephalus, but may also be indicated in cases of:
 * Intracranial hypertension
 * Intracranial hematomas
 * Cerebral edema

Surgical Procedure[edit]

  • The shunt system, consisting of a flexible tube with a valve, is surgically implanted.
  • The valve regulates the flow of CSF and prevents backflow.

Potential Complications[edit]

  • Shunt systems are not without risks and can include infection, blockage, overdrainage, and mechanical failure.
  • Regular monitoring and, in some cases, additional surgeries are required to manage these complications.

Impact on Quality of Life[edit]

  • When effective, cerebral shunts can significantly improve the quality of life for individuals with hydrocephalus.
  • They alleviate symptoms associated with increased ICP, such as headaches, vision problems, and cognitive difficulties.

Advances in Shunt Technology[edit]

  • Recent advancements include programmable shunts that allow for non-invasive adjustments of the flow rate.
  • Ongoing research aims to enhance the reliability and safety of shunt systems.

References[edit]


External Links[edit]

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.